PHARMA BOARDROOM – Inflation’s Impact on Medicine Supply: Challenges for the Off-Patent Industry

19 October 2022

Victor Mendonça, chair of the Generic Market Access Committee at […]

MANUFACTURING CHEMIST – EU supply chain regulation: what will it mean for companies attending CPHI?

17 October 2022

Ahead of her session on “Manufacturing Excellence” at CPHI Frankfurt […]

PHARMACEUTICAL TECHNOLOGY – Inflation drives pharma manufacturing to focus on sustainability

11 October 2022

Inflation is at an all-time high, opening an opportunity for […]

REUTERS – Europe’s generic drugmakers say they may cut output due to energy bills

28 September 2022

The generic drug industry lobby group Medicines for Europe on […]

CORREO FARMACEUTICO – Elisabeth Stampa Stampa, Presidenta de Medicines for Europe y Consejera Delegata de Medichem

31 March 2022

REGULATORY FOCUS – New reports address generics pricing, innovation in the EU

2 December 2021

Open

Open letter: Urgent call to amend the Temporary State Aid Framework to achieve the Recovery and Resiliency Facility objectives

17 November 2021

Margaritis Schinas and Adrian Van Den Hoven visited ELPEN

15 November 2021

Digitalisation the key to efficient EU pharmaceutical regulation and easing of localised drug shortages

27 October 2021

“Digitalisation the key to efficient EU pharmaceutical regulation and easing […]

“Central Role For Industry Beckons As Europe Rebuilds After COVID” – Interview to Rebecca Guntern

25 October 2021

Generics And Biosimilars Must Become A Central Policy Pillar, Says […]